TickerFactsScreenerDevelopers

Arbutus Biopharma Corp (ABUS) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2011: -$7.83M2012: $32.91M2013: -$6.74M2014: -$12.42M2015: -$56.38M2016: -$57.88M2017: -$48.64M2018: -$67.87M2019: -$71.01M2020: -$51.44M2021: -$67.53M2022: -$35.36M2023: -$85.94M2024: -$64.85M2025: -$39.64M-$39.64M
2011Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$39.64M+38.9%
2024-$64.85M+24.5%
2023-$85.94M-143.1%
2022-$35.36M+47.6%
2021-$67.53M-31.3%
2020-$51.44M+27.6%
2019-$71.01M-4.6%
2018-$67.87M-39.5%
2017-$48.64M+16.0%
2016-$57.88M-2.7%
2015-$56.38M-353.9%
2014-$12.42M-84.4%
2013-$6.74M-120.5%
2012$32.91M+520.2%
2011-$7.83M—